Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand

Journal of Pharmaceutical Policy and Practice

Research

Chotirat Nakaranurack¹  Wichai Santimaleeworagun²  Supparat Chanprasert³  Watsa Charoenwaiyachet³  Benjabhorn Weeraphon⁴  Worapong Sungsana⁵  Opass Putcharoen⁶  Pattama Torvorapanit⁶ 

[1] Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai Road, Pathumwan, Bangkok, Thailand;Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand;Department of Pharmacy, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand;Faculty of Pharmaceutical Science, Burapha University, Chonburi, Thailand;Faculty of Pharmacy, Huachiew Chalermprakiet University, Samut Prakan, Thailand;Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Infectious Disease Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

关键词: Pharmacists;    COVID-19;    Coronavirus;    Home isolation;    Drug-related problems;    Telepharmacy;    Pharmaceutical care;   

DOI  :  10.1186/s40545-023-00538-z

 received in 2022-04-29, accepted in 2023-02-10,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundHome isolation has been proposed for coronavirus disease 2019 (COVID-19) patients with mild symptoms to avoid hospital overcrowding. This study aimed to describe the drug-related problems (DRPs) and the pharmaceutical care of home-isolating COVID-19 patients in Thailand.MethodsOur cross-sectional study was undertaken from July 1 to September 30, 2021, at the King Chulalongkorn Memorial Hospital, Thailand. Patients who were ≥ 18 years old, were diagnosed with mild COVID-19 by real-time polymerase chain reaction (RT-PCR), and were able to isolate at home while receiving an antiviral agent and standard symptomatic treatment were enrolled. Infectious disease pharmacists provided a telepharmacy service on days 1 and 3 after the COVID-19 diagnosis.ResultsA total of 197 patients met the study criteria. Their median age was 45 years, and their most common underlying disease was hypertension (44.29%). All patients exhibited excellent anti-COVID-19 drug adherence. We identified 125 DRPs, including adverse reactions (68%), and the unnecessary use of products (62.40%). Moreover, 91 patients (46.19%) reported the use of supplements or herbs, with vitamin C being the main supplement (37.36%). Pharmacists provided 36 recommendations and received 33 questions from COVID-19 patients.ConclusionsOur study demonstrates that telepharmacy is an essential service for detecting and preventing DRPs in home-isolating COVID-19 patients.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 1

Fig. 1

Fig. 6